COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 2104: Articles 21031-21040  | Next

The role of children in the transmission chain of SARS-CoV-2: a systematic review and update of current evidence
Suk, J. E., Vardavas, C., Nikitara, K., Phalkey, R., Leonardi-Bee, J., Pharris, A., Wiltshire, E., Funk, T., Ferland, L., Bundle, N., Semenza, J. C.
10.1101/2020.11.06.20227264 — Posted: 2020-11-09
Non applicability of validated predictive models for intensive care admission and death of COVID-19 patients in a secondary care hospital in Belgium
Parisi, N., Mili, N.
10.1101/2020.11.06.20205799 — Posted: 2020-11-09
Symptomatic SARS-CoV-2 re-infection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response.
Selhorst, P., van Ierssel, S., Michiels, J., Mariën, J., Bartholomeeusen, K., Dirinck, E., Vandamme, S., Jansens, H., Ariën, K. K.
10.1101/2020.11.05.20225052 — Posted: 2020-11-09 Discussion: Offsite
Optimal test-assisted quarantine strategies for COVID-19
Peng, B., Zhou, W., Pettit, R. W., Yu, P., Matos, P., Greninger, A., McCashin, J., Amos, C. I.
10.1101/2020.11.06.20222398 — Posted: 2020-11-09
Team contact sports in times of the COVID-19 pandemic- a scientific concept for the Austrian football league
van der Zee-Neuen, A., Schaffler-Schaden, D., Herfert, J., O Brien, J., Johansson, T., Kutschar, P., Seymer, A., Ludwig, S., Stoeggl, T., Keeley, D., Resch, H., Osterbrink, J., Flamm, M.
10.1101/2020.11.06.20226977 — Posted: 2020-11-08
in vitro: Natural Compounds (Thymol, Carvacrol, Hesperidine, And Thymoquinone) Against SARS-CoV2 Strain Isolated From Egyptian Patients
Seadawy, M. G., Gad, A. F., Harty, B. E., Mohamed, M. F., ELdesoky, M. S., Elfiky, A. A., Ahmed, A., Zekri, A. N.
10.1101/2020.11.07.367649 — Posted: 2020-11-08
Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Liu, Z., VanBlargan, L. A., Rothlauf, P. W., Bloyet, L.-M., Chen, R. E., Stumpf, S., Zhao, H., Errico, J. M., Theel, E. S., Ellebedy, A. H., Fremont, D. H., Diamond, M. S., Whelan, S. P. J.
10.1101/2020.11.06.372037 — Posted: 2020-11-08 Discussion: Offsite
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre-Bosquet, N., Grobben, M., Claireaux, M., de Gast, M., Marlin, R., Chesnais, V., Diry, S., Allen, J. D., Watanabe, Y., Griezen, J. M., Kerster, G., Turner, H. L., van der Straten, K., van der Linden, C. A., Aldon, Y., Naninck, T., Bontjer, I., Burger, J. A., Poniman, M., Mykytyn, A. Z., Okba, N. M. A., Schermer, E. E., van Breemen, M. J., Ravichandran, R., Caniels, T. G., van Schooten, J., Kahlaoui, N., Contreras, V., Lemaitre, J., Chapon, C., Ho Tsong Fang, R., Villaudy, J., Sliepen, K., van der Velden, Y. U., Haagmans, B., de Bree, G. J., Ginoux, E., Ward, A. B., Crispin, M., King, N. P., van der Werf, S., van Gils, M. J., Le Grand, R., Sanders, R. W.
10.1101/2020.11.07.365726 — Posted: 2020-11-08
A zebrafish model for COVID-19 recapitulates olfactory and cardiovascular pathophysiologies caused by SARS-CoV-2
Kraus, A., Casadei, E., Huertas, M., Ye, C., Bradfute, S. B., Boudinot, P., Levraud, J.-P., Salinas, I.
10.1101/2020.11.06.368191 — Posted: 2020-11-08 Discussion: Offsite
Variability of Accessory Proteins Rules the SARS-CoV-2 Pathogenicity
Hassan, S. S., Pal Choudhury, P., Uversky, V. N., Dayhoff, G. W., Aljabali, A. A. A., Uhal, B., Lundstrom, K., Rezaei, N., Seyran, M., Pizzol, D., Adadi, P., Lal, A., Soares, A., Abd El-Aziz, T. M., Kandimalla, R., Tambuwala, M., Azad, G. K., Sherchan, S. P., Baetas-da-Cruz, W., Takayama, K., Serrano Aroca, A., Chauhan, G., Palu, G., Brufsky, A.
10.1101/2020.11.06.372227 — Posted: 2020-11-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).